in

Topical Agent for Hyperhidrosis Wins FDA Approval

Source link : https://www.newshealth.biz/health-news/topical-agent-for-hyperhidrosis-wins-fda-approval/

The FDA approved sofpironium topical gel 12.45% (Sofdra) for primary axillary hyperhidrosis, according to a statement from Botanix Pharmaceuticals. The approval stipulates use in adults and children 9 years or older. According to the company, the product is the first new chemical entity approved to treat primary axillary hyperhidrosis. “The approval of Sofdra is terrific […]

Author : News Health

Publish date : 2024-06-20 17:52:41

Copyright for syndicated content belongs to the linked Source.

« Attribuer la fragilité de l’industrie automobile européenne à des pratiques chinoises déloyales est un peu court. Le mal est beaucoup plus profond »

Who’s next to join Jaguars QB Trevor Lawrence in the $50 Million Club?